IDYA

IDEAYA Biosciences, Inc.

IDYA | News | $39.195 4.27% 170K

(0.0% 1d) (-11.2% 1m) (85.5% 1y) (0.0% 2d) (0.0% 3d) (-6.4% 7d) (Infinity% volume)
Earnings Calendar: 2024-03-05
Market Cap: $ 2,930,399,594
http://www.ideayabio.com
Sec Filling | Patents | 47 employees

(US) IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

cancer molecular diagnostics genetic diagnostics

add to watch list Paper trade email alert is off

Press-releases

IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer
Published: 2024-04-22 (Crawled : 12:00) - biospace.com/
IDYA | News | $39.195 4.27% 170K

Health Technology

| -0.87% | O: -0.82% H: 2.42% C: -0.05%
ide397 lung cancer cell expansion for

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-05 (Crawled : 10:00) - prnewswire.com
IDYA | News | $39.195 4.27% 170K

Health Technology

| -11.33% | O: -2.42% H: 3.02% C: 2.76%
nasdaq grants

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 05, 2024
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
IDYA | News | $39.195 4.27% 170K

Health Technology

| -11.33% | O: -2.42% H: 3.02% C: 2.76%
nasdaq grants

IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event
Published: 2024-04-01 (Crawled : 10:00) - prnewswire.com
IDYA | News | $39.195 4.27% 170K

Health Technology

| -14.37% | O: -0.14% H: 0.89% C: -3.01%

IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
Published: 2024-03-12 (Crawled : 10:00) - prnewswire.com
IDYA | News | $39.195 4.27% 170K

Health Technology

| -13.74% | O: 0.0% H: 5.72% C: 2.71%
ide161 keytruda cancer collaboration

IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events
Published: 2024-03-04 (Crawled : 11:00) - prnewswire.com
IDYA | News | $39.195 4.27% 170K

Health Technology

| -18.67% | O: 0.52% H: 1.96% C: 0.67%

IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Published: 2024-02-20 (Crawled : 11:00) - prnewswire.com
IDYA | News | $39.195 4.27% 170K

Health Technology

| -20.24% | O: -1.08% H: 1.23% C: -5.6%
business update financial results

IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events
Published: 2024-02-01 (Crawled : 11:00) - prnewswire.com
IDYA | News | $39.195 4.27% 170K

Health Technology

| -13.65% | O: 0.3% H: 3.07% C: 1.99%

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-26 (Crawled : 11:00) - prnewswire.com
IDYA | News | $39.195 4.27% 170K

Health Technology

| -11.55% | O: 0.49% H: 0.02% C: -1.22%
nasdaq grants

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - January 26, 2024
Published: 2024-01-26 (Crawled : 15:30) - biospace.com/
IDYA | News | $39.195 4.27% 170K

Health Technology

| -11.55% | O: 0.49% H: 0.02% C: -1.22%
nasdaq grants

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001610717-24-000120	4	2024-03-04	2024-03-01	Buy	A	480000	480000
0001610717-24-000119	4	2024-03-04	2024-03-01	Buy	A	85000	85000
0001610717-24-000053	4	2024-02-12	2024-02-09	Sell	M	23557	224454
0001610717-24-000053	4	2024-02-12	2024-02-08	Sell	M	75815	248011
0001610717-24-000053	4	2024-02-12	2024-02-09	Buy	M	23557	701444
0001610717-24-000053	4	2024-02-12	2024-02-08	Sell	S	75815	677887
0001610717-24-000053	4	2024-02-12	2024-02-08	Buy	M	75815	753702